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In a previous paper (1) it was shown that a strain of Pnettmococcus 
Type I  loses its specificity and virulence when subjected to certain 
unfavorable cultural environments.  Yoshioka (2) has brought about 
a  s~milar process of degradation in strains of Pneumococcus Types II 
and III.  From these studies it is apparent that at least two general 
and  widely  different  forms  exist  among pneumococci of  the  fixed 
types (Types I, II, and III), one comprising the virulent, type-specific, 
so called S strains, and the other including the avirulent, non-specific, 
so called R  strains. 
Both  Griffith  (3)  and Yoshioka found that  antisera prepared by 
using R  strains  for immunization did not  agglutinate the  virulent 
type-specific organisms and did not protect against infection caused 
by them.  On the other hand, R  strains were agglutinated by R  sere 
and  also  by type-specific antipneumococcus sera  regardless of  type. 
Type-speclfic pneumococci are capsulated and capable of elaborat- 
ing  the  type-specific soluble  substances which have been identified 
by  Avery and  Heidelberger  as  the carbohydrate constituent of the 
pneumococcus  cell (4).  Pneumococci  of the R forms are not capsulated 
and  do  not  elaborate  the  soluble substances which endow the cell 
with type specificity.  In sequence with the recent observations of 
Avery and  his  associates  (5-7),  on  the  antigenic properties of  the 
cellular constituents of pneumococcus, it seemed of interest to study 
further the immunological relationships between the so called S and 
R  forms of pneumococci. 
Methods. 
Preparation of Sera.--Type I, II, and III pneumococci were repeatedly grown 
in broth containing dilutions of immune serum of the respective type, until upon 
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plating the cultures only colonies of the rough, avirulent  R form appeared.  From 
ten to twenty transfers  in 1 per cent immune sera were necessary.  Antipneumo- 
coccus sera were then prepared  with the three  type-specific S strains  and were 
called Type I, II, and III S sera, and also with the variant R strains of their respec- 
tive types which were designated Type I, II, and III R sera. 
For the preparation of immune sera, the bacteria from young, actively growing 
cultures were suspended in salt solution and immediately killed at 56°C. to  mini- 
mize  the  amount of autolysis  or  cell solution.  Autolysis  is  undesirable  since 
Avery and Heidelberger  (7) have found that dissolution of the bacterial  bodies is 
accompanied by dissociation of the specific antigenic complex and consequent loss 
of power to provoke type-specific antibodies.  Rabbits were immunized according 
to the method of Cole and Moore (8) by the intravenous  injection of pneumococci 
of the three specific types and of the variant strains derived from them by methods 
already described. 
Sera were absorbed by mixing 10 per  cent dilutions  of the homologous serum 
with  definite volumes  of pneumoco¢cus bodies obtained  by centrifuging  heated 
broth cultures.  For instance,  0.2 cc. of the bacterial  sediment was emulsified in 
2 cc. of the diluted  serum.  The mixture was incubated  for 2 hours at 37°C. and 
placed in the ice box overnight.  The bacteria were then removed from the serum 
by centrifuging.  R  sera usually  required  a  second exposure with  one-twentieth 
volume of pneumococci for complete absorption. 
Autolysates  of  the  pneumococci  were obtained  by suspending  the  bacterial 
sediment from 150 cc. of an 8 hour dextrose broth culture in 10 cc. of salt  solution 
and allowing the cells to disintegrate  at 37°C. for 24 to 48 hours or until autolysis 
was nearly  complete.  The  centrifuged  supernatant  fluids or  autolysates  were 
faintly  opalescent.  Solutions  of  pneumococci  in  bile did  not  give  clear-cut 
reactions and were not used. 
The  pneumococcus  protein  and  the  anti pneumococcus-protein  serum  were 
prepared  according to the methods of Avery and Heidelberger  (4) and Avery and 
Morgan (5). 
Considerable  difficulty  was  encountered  owing  to  the  rapid  autolysis  and 
spontaneous  agglutination  of the II R and III R strains when used for agglutina- 
tion tests.  This was overcome to a large extent by transferring  the strains eight or 
ten times in plain broth and finally killing by heat.  Suspensions of  heat-killed 
pneumococci were used in all agglutination  tests. 
Experiments  with Antipneumococcus Serum.--The  antipneumo- 
coccus serum  (S)  prepared by immunization with intact  cells of the 
type-specific, virulent form contains predominantly an antibody reac- 
tive only with the soluble specific substance of the homologous type. 
However, since cultures may contain both intact cells and a  variable 
amount of degraded ceils  as well  as products of cell  dissolution  (7), 
and  since  in  the  material  used  for  immunization  dissociation  is HOBART  A.  REI~AI'CN  1.09 
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bound  to  occur  in  spite  of precautions  to  prevent it,  some of the 
cell protein becomes free and acting independently of the antigenic 
complex of the intact cell gives rise to an antiprotein immune body 
which is species-specific and distinct from the type-specific antibody. 
The usual antipneumococcus sera apparently contain both forms  of 
antibodies. 
It has been found on previous occasions that all R  strains as well 
as the protein  of pneumococci react in immune S sera regardless of 
type  derivation.  On  the  other  hand,  type-specific  pneumococci 
(S forms) agglutinate only in their corresponding type sera.  Agglu- 
tination and precipitin reactions of Type I-S antipneumococcus serum 
with suspensions and autolysates of various pneumococci are shown 
in Table I. 
In Table I  evidence is presented  that  Type  I  antipneumococcus 
serum  contains  specific  agglutinins  for  homologous  S  strains,  and 
precipitins for the homologous specific substance.  It is not reactive 
with pneumococci of heterologous specific types.  However, in addition 
to the type-specific antibodies there are present agglutinins for cells of 
the R forms, regardless of type derivation, and precipitins which react 
with  autolysates  of  R  strains  and  with  solutions  of pneumococcus 
protein.  It  would  seem,  therefore,  that  antipneumococcus  serum 
contains  the  type-specific antibody together with  antibodies which 
are common to all R  strains and pneumococcus protein. 
If antipneumococcus serum of this nature is absorbed with organ- 
isms of a homologous S type, it is possible to remove the type-specific 
antibody and leave the protein antibody intact.  Table II shows the 
reactions obtained with a serum so treated. 
It  is  apparent  that  neither  the homologous S  strain  nor  soluble 
specific substance derived therefrom is precipitated by the absorbed 
serum.  The  agglutinins  and precipitins  common to  the R  strains, 
however,  remain,  although  somewhat  diminished  in  titre.  It  is 
assumed that the diminution in titre is due to the absorption of some 
of the non-specific antibodies by some degraded forms or products of 
autolyzed pneumococci which appeared in  the S  culture during the 
preparation of the suspension for absorbing. 
Just as it  is  possible  to  absorb  the  type-specific  antibody  from 
antipneumococcus serum  and  leave  the  protein  antibody,  so  it  is HOBART  A.  REIMANN  111 
likewise  possible  to  absorb  the  latter  and  leave  the  former  antibody 
practically  undiminished  in  titre.  Table  III  shows  the  serological 
TABLE  II. 
Agglutination  and Precipitin Reactions with Type LS  Antipneumococcus  Serum 
Absorbed with Type I-S Pneumococci. 
Agglutination.  Precipitation. 
Bacterial suspensions. 
Absorbed 
serum dilutions. 
[:10  1:20  1:40 
Bacterial solutions. 
Type I-S pneumococci ...... 
"  I-R  " 
"  II-R  " 
Type  I  specific substance 
1:40,000 ............... 
Type  I-R  autolysate ....... 
"  II-R  " 
"  III-R  " 
Pneumococcus protein 
solution 1 : 300 ........... 
Control salt solution ....... 
Absorbed 
serum dilution. 
1:10 
+ 
+ 
+ 
+ 
TABLE  III. 
Agglutination  and  Precipitin Reactions with  Type  I-S  Antlpneumococcus  Serum 
Absorbed with Type I-R Pneumococcus. 
Agglutination.  Precipitation. 
Bacterial suspensions. 
Type I-S pneumococci ..... 
"  I-R  "  .... 
"  II-R  "  . 
"  III-R  " 
Absorbed 
serum dilutions. 
1:10,  1:20  1:40 
++++  +++  + 
Absorbed 
seruln  Bacterial solutions,  dilution. 
1:10 
Type I  specific substance 
1:40,000 ..............  ++++ 
Type I-R autolysate ......  -- 
"  II-R  " 
"  III-R  " 
Pneumococcus  protein 
solution 1:300 ..........  -- 
behavior  of  a  type-specific  serum  absorbed  with  an R  strain  of pneu- 
mococcus. 
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the degraded R  forms derived from the same type leaves the titre of 
the type-specific antibody unaffected.  Both the agglutinins for the 
R  forms of pneumococci and the precipitins for autolysates and pneu- 
mococcus protein are completely removed, leaving a  serum reactive 
only with  homologous Type  I-S  pneumococci  and  soluble  specific 
substance derived from them. 
The experiments cited above have been repeated and results similar 
to those for Type I serum have been obtained with antipneumococcus 
sera and the corresponding organisms of Types II and III. 
Several attempts were made to produce a  serum in vivo containing 
only the type-specific antibody.  The usual procedure of immuniza- 
tion was employed with the exception that for each injection organ- 
isms  were  obtained  directly from  an  infected mouse.  The  mouse 
was inoculated intraperitoneally with pneumococci and killed in  12 
hours.  The peritoneal cavity was washed with saline and the suspen- 
sion  immediately centrifuged, washed  once,  and  heated  at  56 °  for 
½ hour.  By this rapid procedure it was hoped that autolysis with its 
coincident dissociation of the carbohydrate and protein constituents 
of the bacterial  antigen would be  eliminated.  However,  after im- 
munization of six rabbits by this method it was found that each serum 
contained varying traces of the non-specific protein antibody, although 
but  slight  in  amount when  compared with  antipneumococcus sera 
prepared in the usual way. 
Experiments  with  Anti-R  Pneumococcus  Serum.--Since  no  type= 
specific substances are elaborated by the R  strains it seemed likely 
that sera prepared against these strains would not contain any of the 
specific antibodies,  but  only those  reacting  in  common with  all  R 
strains.  Agglutination and precipitin reactions against specific and 
degraded strains  of pneumococci by an anti-R  serum are shown in 
Table IV. 
It is evident from Table IV that the anti-R serum does not contain 
any type-specific agglutinins for the S strain from which the R  form 
was  derived.  Neither  does  it  contain  precipitins  for  the  homolo- 
gous soluble specific substance.  Agglutinins are present, however, for 
both homologous and heterologous R  strains.  There are also precip- 
itins for pneumococcus autolysates of all types, both S and R.  The 
autolysates of the S strains obviously contain the free specific element HOBART A.  ILEIMANN  113 
and the free protein, but the latter alone is reactive in R serum.  By 
virtue of its common nature, the protein of each autolysate is therefore 
TABLE  IV. 
Agglutination  and  Precipitin  Reactions  with  Type  I-R  Serum. 
Agglutination.  Precipitation, 
Serum dilutions" 
1:10 11:20 1:40] 
Serum 
dilution,  Bacterial suspensions. 
Type I-S pneum°c°cci" i  i  ]~  ~  ~  "'  "  III-R  II'R  I-l~.  ,,  ,,  "  ." 
Bacterial solutions. 
Type I specific substance 
1:40,000 ............... 
Type I-S autolysate ....... 
"  II-S  " 
"  III-S  " 
"  I-R  " 
"  II-R  "  ........ 
"  III-R  " 
Pneumococcus protein 
solution 1 : 300 ........... 
1:10 
B 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
TABLE  V. 
Agglutinanon  and PrecitHtin Reactions with Type I-R Serum Absorbed with Type 
I-R Pneumococci. 
Agglutination.  Precipitation. 
Bacterial  suspensions. 
Type I-R pneumococci ..... 
II-R  "  . ..... 
"  III-R  " 
Absorbed 
serum dilutions. 
1:10  1:2~  1:40 
Bacterial  solutions. 
2~pe I-S autolysate  ........ 
"  ll-S  " 
"  III-S  "  ........ 
"  I-R  " 
"  II-R  " 
"  III-R  "  ........ 
Pneumococcus protein ...... 
Absorbed 
serum dilutions. 
1:10 
m 
m 
m 
reactive.  Similarly,  pneumococcus protein,  regardless  of  the  form 
from which it is isolated, is precipitated by the R  serum. 
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strain.  This  procedure  removes  the  agglutinins  for  the  R  strains 
and the precipitins for the pneumococcus protein,  leaving the  serum 
inactive.  The agglutination  and precipitin reactions of a  Type I-R 
serum absorbed with a  Type I-R strain are given in Table V.  The 
absorbed serum being inactive does not agglutinate suspensions of the 
R  organisms or precipitate pneumococcus protein either in its purified 
isolated form or as it occurs in cell autolysates. 
Protocols similar  to  Table  IV were  obtained  by  using  II-R  and 
III-R sera.  Reactions similar to those shown in Table V were obtained 
TABLE VI. 
Agglutination  and  Precipitln Reactions  with  Anti  Pneumococcus-Protein  Serum. 
Agglutination.  Precipitation. 
Bactcrlal  suspensions. 
Serum dilutions. 
An  ti pneumo- 
coccus-protein 
Type  I-S  pneumococci.,  t:to 
"  I-R  "  .....  ++ 
+  "  II-R  "  . 
"  III-R  "  . .....  + 
,:,o] 
+ 
Bacterial solutions.  Serum dilution. 
1:10 
Type  I  specific substance 
1:40,000 ................  -- 
Type  I-S  autolysate ........  -b 
"  II-S  "  . .......  + 
"  III-S  "  . ....... [  + 
"  I-R  "  I  + 
"  II-R  "  iiiiiiii  I  + 
"  III-R  "  " .......  I  + 
Pneumococcus  protein  I 
solution 1 : 300 ...........  [  + 
with a III-R serum absorbed with a II-R strain, and with a I-R serum 
absorbed with a  III-R strain of pneumococci. 
Experiments  with  Anti  Pneumococcus-Protein  Serum.--Because  of 
the consistent similarity in precipitin reactions of the pneumococcus 
autolysates,  and  of  the  prepared pneumococcus protein in the fore- 
going  experiments,  it  seemed  of  interest  to  observe  the  serologic 
behavior of a serum prepared against this protein.  The agglutination 
and precipitin reactions of an anti pneurnococcus-protein serum with 
S and R  strains are shown in Table VI. HOBART  A.  REIMANN  115 
It is significant that the reactions in Table VI resemble those shown 
in  Table  IV.  Apparently  sera  prepared  with  R  strains  and  with 
pneumococcus protein  have similar  serologic properties.  The  anti- 
protein element in the serum obviously being common to the protein 
of all types of pneumococci, both S and R, causes a precipitate in all 
of the autolysates and agglutinates suspensions of all R  strains.  The 
intact S organisms are not affected. 
The  similarity  between  the  antiprotein  serum  and  the  anti-R 
serum is further demonstrated by the absorption  of the agglutinins 
in the antiprotein serum with R  strains.  The results are tabulated 
TABLE  VH. 
Agglutination  and  Precipitin  Reactions  with  Anti  Pneumococcus-Protein  Serum 
Absorbed with Type I-R Pneumococci. 
Agglutination.  Precipitation. 
Bacterial suspensions. 
rype I-P. pneumococci. 
"  II-R  " 
"  III-R  " 
Absorbed 
~rumdilufions. 
1:10  1:20  1:40 
Bacterial solutions. 
Type I-S autolysate ..... 
"  II-S  " 
"  III-S  " 
"  I-R  " 
"  II-R  " 
"  III-R  " 
Pneumococcus protein 
solution.. 
.° 
..° 
Absorbed 
serum  1  :dioUtiOn. 
in  Table  VII.  The  resemblance of Table  VII  to  Table  V  is  self- 
evident.  The  agglutinins for the R  strains  and the precipitins  for 
the cell antolysates and pneumococcus protein have been removed, 
leaving an inactive serum. 
DISCUSSION. 
Avery and Neill (6) have shown that solutions of pneumococci have 
antigenic properties  strikingly  different  from  those  of  the  intact 
cells  themselves.  When  cell  solutions  are  used  for  immunization, 
antibodies arise which react with the common protein alone.  On the 116  TYPE-SPECIFIC  AND  DEGRADED  PNEU~OCOCCI 
other hand, when the uninjured bacterial cell is used for immunization, 
antibodies arise which react with the type-specific carbohydrate sub- 
stance.  By virtue of the common properties of the protein constitu- 
ent of pneumococci,  sera containing the antibody to this protein react 
with  the protein from  all  types  of pneumococci.  Antiprotein sera 
obtained by immunization with dissolved pneumococci are similar in 
their serologic reactions to  sera  produced  by  the  injection  of  the 
isolated protein. 
The experiments  recorded  in  the  present  paper  show  that  sera 
prepared  by  immunization  with  pneumococci  of  degraded  types 
(R strains) resemble in their reactions sera prepared by immunization 
with the cell protein alone.  It would seem, therefore, that R  pneu- 
mococci stimulate the formation of antibodies by virtue of the protein 
constituent of the cell body.  Previous mention has been made of the 
absence  of  capsule  formation  and  of  the  associated  specific  sub- 
stance in the R  strains.  Consequently the R  strains, devoid of the 
type-specific antigen,  cannot stimulate the formation of  antibodies 
reactive with  the  type-specific substances  and  therefore have  only 
the  antigenic properties  of  the isolated protein.  Thus, on account 
of  the  common antigenic properties  of  the  protein of all pneumo- 
cocci it is not surprising that R  sera  cross-agglutinate with R  strains 
regardless of type derivation, and precipitate the free protein in auto- 
lysates of S strains. 
The results on the whole substantiate the deductions of Avery and 
Heidelberger (7)  regarding the relationship of the carbohydrate and 
protein constituents of the pneumococcus cell. 
Assuming that  the  loss  in  type  specificity of  an  S  strain  after 
degradation to the R form is due to a loss in the capacity to elaborate 
the type-specific carbohydrate substance associated with the capsule, 
and that the R  form is merely an S cell minus this factor, it is pos- 
sible to interpret the  immune mechanism involved according to  the 
views of these authors.  Applying these conclusions to  the results of 
their study it is only necessary to substitute in their scheme (7, Fig. 1) 
the symbol for protein (P)  by R  representing an R cell.  The type- 
specific  cell would  then be  an  S-R combination and  the  R  cell,  R 
alone. 
The  confusing cross-reactions occasionally encountered in  typing HOBART  A.  REIMANN  117 
pneumococci  with  the usual diagnostic sera, and the cross-reactions 
occasionally  noted  in  S  cultures  containing  unusual  numbers  of 
degraded pneumococci, are thus in part explained. 
CONCLUSIONS. 
1.  Immune sera prepared with the degraded or  variant  forms  of 
pneumococci (R strains) are similar in their reactions to sera prepared 
with the protein or cell solutions of pneumococci.  They contain anti- 
bodies reactive with the protein of all types of pneumococci, but no 
antibodies  reactive  with  the  type-specific  substances. 
2.  Pneumococci of the variant or R form, regardless of type deriva- 
tion, are serologically identical and have the antigenic characteristics 
of pneumococcus protein.  They evoke the species-specific and not the 
type-specific antibodies. 
3.  Antipneumococcus sera obtained by immunization with S strains 
may contain species-specific antibodies in addition to those which are 
type-specific.  Each  kind  of  antibody  can  be  removed  separately 
from these  sera by selective absorption  with  the R  or  S  strains  of 
pneumococci. 
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